期刊文献+

血清骨桥蛋白对冠状动脉支架植入术后再狭窄的预测价值 被引量:10

The Predictive Value of Serum Osteopontin on Restenosis after Coronary Artery Stent Implantation
暂未订购
导出
摘要 目的探讨经皮冠状动脉介入治疗(PCI)后患者血清骨桥蛋白(OPN)水平对支架内再狭窄(ISR)的预测价值。方法收集我院接受PCI后随访1年、复查冠状动脉造影检查的患者120例,其中男68例,女52例,平均年龄为59.38±11.13岁。根据冠状动脉造影结果分为再狭窄组和无再狭窄组,复查冠状动脉造影时检测两组患者血清OPN等生物化学指标,比较两组临床资料、OPN等生物化学指标水平。结果再狭窄组患者血清OPN水平显著高于无再狭窄组,差异有统计学意义(4.79±1.09μg/L比3.11±1.13μg/L,P〈0.01)。Logistic多因素回归分析显示,OPN升高是PCI后ISR发生的独立危险因素(OR=3.034,95%CI为1.532~6.007,P〈0.01)。在OPN预测ISR能力的ROC曲线中,其曲线下面积为0.872,95%CI为0.770~0.975,P〈0.01;当OPN取4.16μg/L时,其阳性预测价值为56.5%,阴性预测价值为95.9%,敏感性为76.5%,特异性为89.3%,准确性为88.3%。结论 PCI后患者血清OPN水平与ISR密切相关,血清OPN的水平对ISR的发生具有一定的预测价值,尤其是其阴性预测价值高。 Aim To explore the predictive value of serum osteopontin( OPN) level on in-stent restenosis( ISR)after percutaneous coronary intervention( PCI). Methods A total of 120 patients( 68 males and 52 females) with acute coronary syndrome or stable angina pectoris successfully treated with PCI were collected,who were followed-up for 1year and reexamined with coronary angiography( CAG). The average age of the patients was 59. 38 ± 11. 13. According to the results of CAG,study subjects were divided into ISR group and non-ISR group. Clinical data,serum OPN and other biochemical patameters were analyzed and compared between two groups. Results The level of serum OPN was significantly higher in ISR group than that in non-ISR group( 4. 79 ± 1. 09 μg / L vs 3. 11 ± 1. 13 μg / L,P〈 0. 01). Multivariate Logistic regression analysis revealed that high serum OPN was an independent risk factor of ISR( OR = 3. 034,95%CI: 1. 532 ~ 6. 007,P〈 0. 01). Area under the receiver operating characteristic curve( ROC) for OPN in evaluating prognosis of ISR patients was 0. 872( 95% CI: 0. 770 ~ 0. 975,P〈 0. 01). The optimal cut-off value of OPN was 4. 16μg /L,at that point,the positive predictive rate for ISR was 56. 5%,negative rate was 95. 9%,sensitivity was 76. 5%,specificity was 89. 3%,and accuracy was 88. 3%. Conclusions Serum OPN level is closely related with ISR after PCI. It has a certain predictive value for the occurrence of ISR,and its negative rate is especially high.
出处 《中国动脉硬化杂志》 CAS 北大核心 2015年第9期911-914,共4页 Chinese Journal of Arteriosclerosis
基金 辽宁省高等学校创新团队项目(LT2012016)
关键词 经皮冠状动脉介入治疗 支架内再狭窄 骨桥蛋白 Percutaneous Coronary Intervention In-stent Restenosis Osteopontin
  • 相关文献

参考文献17

  • 1Momiyama Y, Ohmori R, Fayad ZA, et al. Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis [J]. Atherosclerosis, 2010, 210 (2) : 668 -670.
  • 2Remus EW, Lyle AN, Weiss D, et al. miR181a protects against angiotensin H-induced osleopontin expression in vascular smootb muscle cells[J]. Atherosclerosis, 2013, 228(1 ) : 168-174.
  • 3Vaquerizo B, Serra A, Miranda-Guardiola F, et al. One-year out-comes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multi- center registry [J]. Interv Cardiol, 2011, 24 (6) : 518-528.
  • 4杨蕾,王丽娟.冠状动脉支架内再狭窄的相关性因素分析[J].中国动脉硬化杂志,2013,21(5):449-453. 被引量:32
  • 5Osherov AB, Gotha L, Cheema AN, et al. Proteins mediating colla- gen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy [J]. Cardiovasc Res, 2011, 91 ( 1) : 16 -26.
  • 6徐健,冯丰,刘闺男.骨桥蛋白特异性siRNA抑制大鼠球囊损伤动脉内膜的增生[J].中国老年学杂志,2013,33(11):2597-2601. 被引量:3
  • 7Liu D, Cui W, Liu B, et al. Atorvastatin protects vaseular smooth muscle cells from TGF-β1-stimulated calcification by inducing auto- phagy via suppression of the β-catenin pathway [J]. Cell Physiol Biochem, 2014, 33(1): 129-141.
  • 8Liu QF, Yu HW, You L, et al. Apelin-13-induced pruliteration and migration induced of rat vascular smooth muscle cells is mediated by the upregulation of Egr-1 [J]. Biochem Biophys Rcs Commun, 2013, 439(2) : 235-240.
  • 9Goncharova EA, Khavin IS, Goncharov DA, et al. Differential effects of formoterol on thrombin and PDGF-induced proliferation of human pulmonary arterial vascular smooth muscle cells [J]. Rcspir Res, 2012, 13(1): 109-120.
  • 10刘志江,石蓓,许官学,赵然尊,沈长银,王正龙.骨髓间充质干细胞移植对兔颈动脉球囊损伤后再狭窄的影响[J].中国动脉硬化杂志,2013,21(1):22-27. 被引量:10

二级参考文献38

  • 1罗彤,杨跃进,宋蓉,高润霖,陈纪林,乔树宾,秦学文,姚民,刘海波,吴永健,陈在嘉.首次心肌梗死患者878例冠状动脉病变的特点分析[J].中华医学杂志,2004,84(11):910-914. 被引量:21
  • 2武晓静,黄岚,周骐,宋耀明,李爱民,晋军.骨髓基质干细胞种植体外修复内皮及对血管平滑肌细胞增生的影响[J].中华老年心脑血管病杂志,2005,7(3):188-191. 被引量:14
  • 3田土.骨髓间质干细胞分化为内皮细胞增加血管密度改善慢性缺血狗的心功能[J].岭南心血管病杂志,2005,11(5):371-371. 被引量:181
  • 4Miettinen TA, Gylling H, Nissinen MJ. The role of serum non-cholesterol sterols as surrogate markers of absolute cho- lesterol synthesis and absorption [ J ]. Nutr Metab Cardio- vasc Dis, 2011, 21(10) : 765-769.
  • 5Pathmaja P, Robert HK, Steven EK, et al. Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity [ J ]. Am J Clin Nutr, 2011, 94(5) : 1 182-188.
  • 6Gylling H, Hallikainen M, Nissinen M J, et al. Very high plant stanol intake and serum plant stanols and non-choles- terol sterols[J]. Eur J Nutr, 2010, 49(2) : 111-117.
  • 7Abbott JD, Voss MR, Nakamure M, et al. Unrestricted use of drug-elutin stents compared with bare-metal stents in routine clinical practice: findings from the Nation Heart, Lung, and Blood Institute Dynamic Registry [ J ]. J Am Coil Cardiol, 2007, 50(21): 2 029-036.
  • 8Mehran R, Danges G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: classification and implica- tions for long-term outcome [ J ]. Circulation, 1999, 100 (18): 1 872-878.
  • 9Moses JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versusstandard stents in patients with stenosis in a native coronary artery[J].NEngl J Med,2003;349(14):1315-23.
  • 10Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of asirolimus-eluting stent with a standard stent for coronary revascularization[J].N Engl J Med,2002;346(23): 1773-80.

共引文献42

同被引文献82

  • 1涂曦文,彭佑铭,唐东兴,谭太发,李丽文.维持性血液透析患者血管钙化及相关因素分析[J].中国动脉硬化杂志,2015,23(6):613-616. 被引量:25
  • 2Lyu Y,Jiang X,Dai W.The roles of a novel inflammatory neopterin in subjects with coronary atherosclerotic heart disease[J].Int Immunopharmacol,2015;24(2):169-72.
  • 3Dai W,Li Y,Lv YN,et al.The roles of a novel anti-inflammatory factor,milk fat globule-epidermal growth factor 8,in patients with coronary atherosclerotic heart disease[J].Atherosclerosis,2014;233(2):661-5.
  • 4Kotseva K,De Bacquer D,Jennings C,et al.Time trends in lifestyle,risk factor control,and use of evidence-based medications in patients with coronary heart disease in europe:results from 3 euroaspire surveys,1999-2013[J].Glob Heart,2016;24(4):90-2.
  • 5Li J,Zhang L,Xie NZ,et al.Relationship between the cholesterol ester transfer protein Taq IB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease[J].Genet Mol Res,2014;13(1):2140-8.
  • 6Zhong Y,Wang N,Xu H,et al.Ischemia-modified albumin in stable coronary atherosclerotic heart disease:clinical diagnosis and risk stratification[J].Coron Artery Dis,2012;23(8):538-41.
  • 7Tu rker Y. Role of tirofiban with dual antiplatelet therapy in pa- tients with STEMI undergoing primary PCI [J]. Anatol J Car diol, 2015, 15(11):956.
  • 8Kaymaz C, Kele8 N,C) zdemir N, et al. The effects of tirofihan infusion on clinical and angiographic outcomes of patients with STEMIundergoing primary PCI [J].Anatol J Cardiol, 2015, 15 (11) :899-906.
  • 9Mrclovic I, Savic L, Lasica R, et al. Efficacy and safety of tiro- fiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propen sity analysis using the Clinical Center of SerbiaSTEMI Register [J]. Eur Heart J Acute Cardiovasc Care, 2014, 3(1) :56-66.
  • 10Rakowski T, Siudak Z, Dziewierz A, et al. Prehospital clopi- dogrel administration in patients with ST-segment elevation myocardial infarction treated with primary PCL: real life experi ence from the multicenter NRDES registry [J]. J Invasive Car- diol, 2016, 28(6):E56-58.

引证文献10

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部